Three-Month Dry Spell For EU PRIME Scheme

Not one of the applications reviewed by the European Medicines Agency this year for a place on its scheme for drugs for unmet medical needs has made the grade. Meanwhile, the agency recently explained how applicants could improve their chances of getting accepted on the initiative.

Calendar — Requests for PRIME designation are reviewed at the monthly CHMP meetings • Source: Alamy

For the third month in a row, there have been no new entries to the European Medicines Agency’s priority medicines (PRIME) scheme for developing promising medicines for unmet medical needs and getting them to patients faster.

The nine applications that the EMA considered for a place on the scheme during the first three months of 2022...